View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
July 21, 2021

North America’s medical devices industry saw a drop of 6.52% in deal activity during June 2021

North America’s medical devices industry saw a drop of 6.52% in deal activity during June 2021, when compared with the last 12-month average, led by GIC, Hellman & Friedman, The Blackstone Group and The Carlyle Group’s $34bn private equity deal with Medline Industries, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 86 medical devices industry deals worth $37.2bn were announced for the region in June 2021, against the 12-month average of 92 deals.

Of all the deal types, venture financing saw most activity in June 2021 with 57 transactions, representing a 66.3% share for the region.

In second place was M&A with 20 deals, followed by private equity deals with nine transactions, respectively capturing a 23.3% and 10.5% share of the overall deal activity for the month.

In terms of value of deals, private equity was the leading category in North America’s medical devices industry with $34.42bn, while venture financing and M&A deals totalled $1.63bn and $1.17bn, respectively.

North America medical devices industry deals in June 2021: Top deals

The top five medical devices deals accounted for 96.1% of the overall value during June 2021.

The combined value of the top five medical devices deals stood at $35.76bn, against the overall value of $37.2bn recorded for the month.

The top five medical devices industry deals of June 2021 tracked by GlobalData were:

1) GIC, Hellman & Friedman, The Blackstone Group and The Carlyle Group’s $34bn private equity deal with Medline Industries

2) The $1bn acquisition deal with Paramit by Tecan Group

3) Counterpoint Global, Janus Henderson Investors, Logos Global Management, Meritech Capital Partners and T Rowe Price Associates’ $276m venture financing of Element Biosciences

4) The $255m venture financing of InSilico Medicine by B Capital Group Management, Baidu Ventures, Bold Capital Partners, CITIC Industrial Investment Fund Management, Deerfield ManagementLP, Eight Roads Ventures, Formic Ventures, Lake Bleu Capital, Lilly Asia ventures, Maison Capital Group, Mirae Asset Capital, Orbimed Advisors, Pavilion Capital Partners, President International Development, Qiming Venture Partners, Sage Partners, Sequoia Capital China, Sinovation Ventures and Warburg Pincus

5) Goldman Sachs Asset Management’s private equity deal with 4G Clinical for $230m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU